CD14 and type 1 diabetes mellitus: The aim of our study therefore was to provide quantitative data on CD14++CD16− and CD14+CD16+ monocyte subsets in juvenile-onset complication-free diabetes mellitus type 1 and to compare them with the corresponding values in the healthy age- and sex-matched control group.